| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 310.51B | 302.68B | 261.60B | 272.17B | 253.57B | 249.20B |
| Gross Profit | 39.17B | 38.82B | 33.39B | 31.03B | 28.02B | 25.58B |
| EBITDA | 12.00B | 14.39B | 11.57B | 11.17B | 8.95B | 7.95B |
| Net Income | 5.99B | 6.74B | 5.94B | 5.78B | 4.63B | 3.84B |
Balance Sheet | ||||||
| Total Assets | 190.36B | 183.63B | 162.02B | 147.99B | 132.09B | 118.64B |
| Cash, Cash Equivalents and Short-Term Investments | 7.53B | 7.51B | 8.45B | 7.05B | 6.54B | 7.10B |
| Total Debt | 85.25B | 79.92B | 74.62B | 68.97B | 58.12B | 51.17B |
| Total Liabilities | 120.31B | 115.27B | 103.16B | 101.02B | 89.91B | 78.67B |
| Stockholders Equity | 68.30B | 66.52B | 58.98B | 47.54B | 42.70B | 40.38B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -314.00M | -7.06B | -8.54B | -5.99B | 3.60B |
| Operating Cash Flow | 0.00 | 5.84B | -1.72B | -6.24B | -1.13B | 6.00B |
| Investing Cash Flow | 0.00 | -9.00B | -5.71B | -2.34B | -5.22B | -527.00M |
| Financing Cash Flow | 0.00 | 2.15B | 8.52B | 9.01B | 5.74B | -4.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥1.12T | 13.07 | 13.07% | 1.82% | 3.64% | 5.31% | |
73 Outperform | ¥417.06B | 10.77 | 10.18% | 2.56% | 3.87% | 29.64% | |
72 Outperform | ¥491.90B | 15.17 | 9.86% | 2.58% | 1.08% | 2.71% | |
71 Outperform | ¥59.66B | 5.05 | 10.55% | 2.68% | 15.22% | 4.80% | |
64 Neutral | ¥32.61B | 7.86 | ― | 1.96% | 0.16% | 10.88% | |
63 Neutral | ¥692.97B | 15.19 | 6.04% | 2.04% | 5.55% | 27.03% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |